Speaker illustration

Professor Udo Bavendiek

Hannover Medical School, Hannover (Germany)

Digitoxin serum concentrations affecting patient safety and potential outcome in patients with HFrEF - analyses of the ongoing DIGIT-HF-trial

Event: ESC Congress 2017

Topic: Pharmacologic therapy

Session: Chronic heart failure (CHF)

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb